Skip to main content
Clinical Trials/NCT05091892
NCT05091892
Completed
Not Applicable

The Effect of a Specific Hydrotherapy Program on the Movement From Lying Down to Sitting Position for Children With Cerebral Palsy

University of Thessaly1 site in 1 country40 target enrollmentSeptember 1, 2021
ConditionsCerebral Palsy

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cerebral Palsy
Sponsor
University of Thessaly
Enrollment
40
Locations
1
Primary Endpoint
GMFM
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The purpose of this study is to investigate the effect of a very specific hydrotherapy programm on the movement from lying down to sitting position for children with CP

Detailed Description

40 children aged 5-11 years with cerebral palsy and difficulty in the transfer activity from lying down to sitting position were randomly divided into 2 groups of 20 children, a land group and a water group. The children of the land attended a neurodevelopmental treatment program and the water group a very specific program in hydrotherapy on combined rotation at all levels. The water program was implemented by specialized physiotherapists in hydrotherapy. The duration of the program for both groups was 3 months. On the first and last day of the intervention, an evaluation of all children was performed using the GMFM and PBS evaluation tests of the evaluation parameters of the transfer from the lying position to the sitting position.

Registry
clinicaltrials.gov
Start Date
September 1, 2021
End Date
March 30, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Konstantinos Chandolias

Dr Konstantinos Chandolias

University of Thessaly

Eligibility Criteria

Inclusion Criteria

  • Cerebral palsy
  • DIfficulties from lying down to sitting posistion

Exclusion Criteria

  • Surgery or injection of botilium toxin in the last year.
  • Scheduled surgery or injection of botilium toxin.
  • Uncontrolled seizures.
  • Do not run elementary commands or play a test representation.
  • Syndromes without OP.
  • Serious vision problem.
  • Absence from the treatment program for more than a week.

Outcomes

Primary Outcomes

GMFM

Time Frame: 3 months

Gross Motor Function Measurement

PBS

Time Frame: 3 months

Paediatric Balance test

Study Sites (1)

Loading locations...

Similar Trials